Lack of association between common polymorphisms in genes of the renin-angiotensin system and mortality after myocardial infarction

Cardiology

Volumn 103, Issue 4, 2005, Pages 185-188

  Andrikopoulos, George K ^a   Tzeis, Stylianos M ^a   Needham, Edward W ^f   Richter, Dimitri J ^b   Zairis, Michalis N ^d   Gialafos, Elias J ^c   Kardaras, Fotios G ^a   Foussas, Stefanos G ^d   Stefanadis, Christodoulos I ^c   Toutouzas, Pavlos K ^f   Mattu, Raj ^e  

^a EVANGELISMOS HOSPITAL   (Greece)

^b Athens Euroclinic   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f Hellenic Heart Foundation   (Greece)

Author keywords

Angiotensin converting enzyme; Angiotensin II type 1 receptor; Mortality; Myocardial infarction; Polymorphisms; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT;

DNA TRANSPOSABLE ELEMENTS; FEMALE; GENE FREQUENCY; GENOTYPE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; PEPTIDE HYDROLASES; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SEQUENCE DELETION; SURVIVAL RATE; VARIATION (GENETICS); VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 21044439702     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084592     Document Type: Article

References (18)

1. Malik FS, Lavie CJ, Mehra MR, Milani RV, Re RN: Renin-angiotensin system: Genes to bedside. Am Heart J 1997;134:514-526.
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
3. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-913.
4. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-1388.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
6. Keavney B, McKenzie C, Parish S, Palmer A, Clark S, Youngman L, Delepine M, Lathrop M, Peto R, Collins R: Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000;355:434-442.
7. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin- converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
8. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998;97:1766-1772.
9. Pinto YM, van Gilst WH, Kingma JH, Schunkert H: Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol 1995;25:1622-1626.
10. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
11. Davis GK, Millner RW, Roberts DH: Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: Effect of ACE gene insertion/deletion polymorphism and left ventricular function. Eur J Heart Fail 2000;2:253-256.
12. Samani NJ, O'Toole L, Martin D, Rai H, Fletcher S, Lodwick D, Thompson JR, Morice AH, Channer K, Woods KL: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol 1996;28:338-344.
13. Yoshida M, Iwai N, Ohmichi N, Izumi M, Nakamura Y, Kinoshita M: D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction. Int J Cardiol 1999;70:119-125.
14. Palmer BR, Pilbrow AP, Yandle TG, Frampton CM, Richards AM, Nicholls MG, Cameron VA: Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. J Am Coll Cardiol 2003;41:729-736.
15. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas P: Risk stratification of coronary heart disease through established and emerging lifestyle factors in a Mediterranean population: CARDIO2000 epidemiological study. J Cardiovasc Risk 2001;8:329-335.
16. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas P: Risk stratification of coronary heart disease in Greece: Final results from the CARDIO2000 Epidemiological Study. Prev Med 2002;35:548-556.
17. EUROASPIRE II Study Group: Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-572.
18. Andrikopoulos GK, Richter DJ, Dilaveris PE, Pipilis A, Zaharoulis A, Gialafos JE, Toutouzas PK, Chimonas ET: In-hospital mortality of habitual cigarette smokers after acute myocardial infarction. The smoker's paradox in a countrywide study. Eur Heart J 2001;22:776-784.